```json
{
"content": [
{
"type": "paragraph",
"content": "Animal External Dewormer industry trends have been shaped by strategic collaborations and technological innovation over the past 18 months. Key players such as Zoetis and Ceva Santé Animale have formed partnerships to co-develop next-generation parasiticides, leveraging combined R&D expertise to address resistance challenges. Meanwhile, mergers & acquisitions have intensified, with Elanco Animal Health acquiring a stake in a biotech startup specializing in RNA-based deworming solutions, signaling a shift toward precision-targeted therapies."
},
{
"type": "paragraph",
"content": Regulatory changes in the EU and US have driven reformulations of existing products to meet stricter residue limits in livestock, pushing manufacturers to adopt greener synthesis methods. Consumer demand for natural and sustainable alternatives has spurred launches like Bimeda’s plant-based topical dewormer, which gained traction in organic farming segments. Funding rounds have also accelerated, with startups such as Verdesure securing $25M in Series B financing to scale their AI-powered livestock health monitoring systems, integrating deworming protocols with real-time data analytics. These trends underscore a market prioritizing efficacy, compliance, and sustainability."
}
]
}
```
